Gene · 2829
Papers1,709
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,709
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Ferroptosis, autophagy, tumor and immunity. | Heliyon | 2023 | 37810047 | PubTator, text mining | PubMed |
| Identification of human genetic variants modulating the course of COVID-19 infection with importance in other viral infections. | Front Genet | 2023 | 37795240 | PubTator, text mining | PubMed |
Interactions of Indoleamine 2,3-dioxygenase-expressing LAMP3+ dendritic cells with CD4+ regulatory T cells and CD8+ exhausted T cells: synergistically remodeling of the immunosuppressive microenvironment in cervical cancer and therapeutic implications. | Cancer Commun (Lond) | 2023 | 37794698 | PubTator, text mining | PubMed |
| STARD12/14 are diagnostic and prognostic biomarkers of lung adenocarcinoma associated with epigenetic regulation, immune infiltration and ferroptosis. | Int J Med Sci | 2023 | 37790851 | PubTator, text mining | PubMed |
| Unravelling the role of immune cells and FN1 in the recurrence and therapeutic process of skull base chordoma. | Clin Transl Med | 2023 | 37784253 | PubTator, text mining | PubMed |
| Characteristics and anatomic location of PD-1+TCF1+ stem-like CD8 T cells in chronic viral infection and cancer. | Proc Natl Acad Sci U S A | 2023 | 37782797 | PubTator, text mining | PubMed |
| Dendritic cell vaccine of gliomas: challenges from bench to bed. | Front Immunol | 2023 | 37781367 | PubTator, text mining | PubMed |
| Single-cell analysis of graft-infiltrating host cells identifies caspase-1 as a potential therapeutic target for heart transplant rejection. | Front Immunol | 2023 | 37781362 | PubTator, text mining | PubMed |
| Enhanced Vaccine Immunogenicity Enabled by Targeted Cytosolic Delivery of Tumor Antigens into Dendritic Cells. | ACS Cent Sci | 2023 | 37780364 | PubTator, text mining | PubMed |
| Current perspective on biological properties of plasmacytoid dendritic cells and dysfunction in gut. | Immun Inflamm Dis | 2023 | 37773693 | PubTator, text mining | PubMed |
| rs71327024 Associated with COVID-19 Hospitalization Reduces CXCR6 Promoter Activity in Human CD4+ T Cells via Disruption of c-Myb Binding. | Int J Mol Sci | 2023 | 37762093 | PubTator, text mining | PubMed |
| Interplay of Chemokines Receptors, Toll-like Receptors, and Host Immunological Pathways. | Biomedicines | 2023 | 37760825 | PubTator, text mining | PubMed |
| Association of IFNAR2 rs2236757 and OAS3 rs10735079 Polymorphisms with Susceptibility to COVID-19 Infection and Severity in Palestine. | Interdiscip Perspect Infect Dis | 2023 | 37745867 | PubTator, text mining | PubMed |
| Mapping the chemotactic landscape in NK cells reveals subset-specific synergistic migratory responses to dual chemokine receptor ligation. | EBioMedicine | 2023 | 37741009 | PubTator, text mining | PubMed |
| DeepCCI: a deep learning framework for identifying cell-cell interactions from single-cell RNA sequencing data. | Bioinformatics | 2023 | 37740953 | PubTator, text mining | PubMed |
| A GWAS in the pandemic epicenter highlights the severe COVID-19 risk locus introgressed by Neanderthals. | iScience | 2023 | 37731612 | PubTator, text mining | PubMed |
| Cyclone: an accessible pipeline to analyze, evaluate, and optimize multiparametric cytometry data. | Front Immunol | 2023 | 37731497 | PubTator, text mining | PubMed |
| Human CD34+-derived complete plasmacytoid and conventional dendritic cell vaccine effectively induces antigen-specific CD8+ T cell and NK cell responses in vitro and in vivo. | Cell Mol Life Sci | 2023 | 37728691 | PubTator, text mining | PubMed |
| Controlling Antigen Fate in Therapeutic Cancer Vaccines by Targeting Dendritic Cell Receptors. | Mol Pharm | 2023 | 37721387 | PubTator, text mining | PubMed |
| A comprehensive analysis of MYO6 as a promising biomarker for diagnosis, prognosis, and immunity in clear cell renal cell carcinoma. | Transl Cancer Res | 2023 | 37701098 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2829/papers?page=9